{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T18:40:04Z","timestamp":1791830404629,"version":"4.3.4"},"reference-count":43,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T00:00:00Z","timestamp":1765670400000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Complete renal response (CRR) is a primary goal in lupus nephritis (LN) management. We examined the prevalence and predictors of sustained CRR (sCRR) and long-term outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We included 142 inception cohort patients with biopsy-proven LN from two academic centres. We assessed the prevalence of sCRR achievement for \u226512\u2009months and the impact of sCRR duration on renal flares, severe kidney function decline (\u226530% eGFR decline compared with baseline), a composite end-stage kidney disease (ESKD) or death outcome, and disease damage. We analysed data over a median 121-month follow-up, using linear, logistic and Cox regression models.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 83% of patients achieved sCRR for \u226512\u2009months, 56.3% for \u22655\u2009years and 20.4% for \u226510\u2009years. Persistent hydroxychloroquine use (adjusted HR: 1.86, P\u2009=\u20090.004), non-nephrotic baseline proteinuria (adjusted HR: 1.71, P\u2009=\u20090.016) and class III vs class IV LN (HR: 1.89, P\u2009=\u20090.018) were associated with earlier sCRR achievement. The 5- and 10-year post-sCRR risks for renal flares decreased for every additional year on CRR. sCRR duration rather than its mere achievement reduced the risk of \u226530% eGFR decline (adjusted OR: 0.81\/year, P\u2009=\u20090.015) and composite ESKD\/death (adjusted HR: 0.75\/year, P\u2009=\u20090.001). sCRR\u2009\u2265\u200912\u2009months protected against damage accrual (adjusted \u03b2-coef=\u22121.17, P\u2009&amp;lt;\u20090.001). Among those with \u2265100-month follow-up, sCRR\u2009\u2265\u20094\u2009years protected against severe kidney function decline (adjusted OR: 0.10, P\u2009=\u20090.005), ESKD\/death (adjusted HR: 0.11, P\u2009=\u20090.043) and damage accrual (adjusted \u03b2-coef=\u20130.81, P\u2009=\u20090.012).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Persistent hydroxychloroquine, non-nephrotic baseline proteinuria and class III vs IV are associated with earlier sCRR. sCRR \u22654\u2009years protects against \u226530% eGFR decline, composite ESKD\/death and damage.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/rheumatology\/keaf677","type":"journal-article","created":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T13:10:40Z","timestamp":1765372240000},"source":"Crossref","is-referenced-by-count":2,"title":["Predictors and long-term impact of sustained complete renal response in lupus nephritis patients over a median 10-year follow-up"],"prefix":"10.1093","volume":"65","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3314-3329","authenticated-orcid":false,"given":"Ioannis E","family":"Michelakis","sequence":"first","affiliation":[{"name":"First Department of Propaedeutic Internal Medicine, Joint Academic Rheumatology Program, Laiko Hospital, Medical School, National and Kapodistrian University of Athens , Athens,","place":["Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9082-6302","authenticated-orcid":false,"given":"Eleni","family":"Kapsia","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Renal Transplantation, Laiko Hospital, Medical School, National and Kapodistrian University of Athens , Athens,","place":["Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8202-2892","authenticated-orcid":false,"given":"John N","family":"Boletis","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Renal Transplantation, Laiko Hospital, Medical School, National and Kapodistrian University of Athens , Athens,","place":["Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5920-3086","authenticated-orcid":false,"given":"Smaragdi","family":"Marinaki","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Renal Transplantation, Laiko Hospital, Medical School, National and Kapodistrian University of Athens , Athens,","place":["Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5484-2930","authenticated-orcid":false,"given":"Petros P","family":"Sfikakis","sequence":"additional","affiliation":[{"name":"First Department of Propaedeutic Internal Medicine, Joint Academic Rheumatology Program, Laiko Hospital, Medical School, National and Kapodistrian University of Athens , Athens,","place":["Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2238-0975","authenticated-orcid":false,"given":"Maria G","family":"Tektonidou","sequence":"additional","affiliation":[{"name":"First Department of Propaedeutic Internal Medicine, Joint Academic Rheumatology Program, Laiko Hospital, Medical School, National and Kapodistrian University of Athens , Athens,","place":["Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,12,13]]},"reference":[{"key":"2026031913415789000_keaf677-B1","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1093\/rheumatology\/kev311","article-title":"The frequency and outcome of lupus nephritis: results from an international inception cohort study","volume":"55","author":"Hanly","year":"2016","journal-title":"Rheumatology (United Kingdom)"},{"key":"2026031913415789000_keaf677-B2","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41572-019-0141-9","article-title":"Lupus nephritis","volume":"6","author":"Anders","year":"2020","journal-title":"Nat Rev Dis Primers"},{"key":"2026031913415789000_keaf677-B3","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1136\/annrheumdis-2017-211663","article-title":"Survival in adults and children with systemic lupus erythematosus: a systematic review and Bayesian meta-analysis of studies from 1950 to 2016","volume":"76","author":"Tektonidou","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"2026031913415789000_keaf677-B4","doi-asserted-by":"crossref","first-page":"222","DOI":"10.3899\/jrheum.191094","article-title":"Risk of renal failure within 10 or 20 years of systemic lupus erythematosus diagnosis","volume":"48","author":"Petri","year":"2021","journal-title":"J Rheumatol"},{"key":"2026031913415789000_keaf677-B5","doi-asserted-by":"crossref","first-page":"3248","DOI":"10.1093\/ndt\/gfs073","article-title":"Survival analysis and causes of mortality in patients with lupus nephritis","volume":"27","author":"Yap","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"2026031913415789000_keaf677-B6","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1002\/art.39594","article-title":"Risk of end-stage renal disease in patients with lupus nephritis, 1971-2015: a systematic review and Bayesian meta-analysis","volume":"68","author":"Tektonidou","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"2026031913415789000_keaf677-B7","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1136\/annrheumdis-2020-216924","article-title":"2019 Update of the Joint European League against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR\/ERA-EDTA) recommendations for the management of lupus nephritis","volume":"79","author":"Fanouriakis","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"2026031913415789000_keaf677-B8","doi-asserted-by":"crossref","first-page":"5017","DOI":"10.3390\/jcm11175017","article-title":"Predictors of early response, flares, and long-term adverse renal outcomes in proliferative lupus nephritis: a 100-month median follow-up of an inception cohort","volume":"11","author":"Kapsia","year":"2022","journal-title":"J Clin Med"},{"key":"2026031913415789000_keaf677-B9","doi-asserted-by":"crossref","first-page":"46","DOI":"10.2215\/CJN.03280807","article-title":"Value of a complete or partial remission in severe lupus nephritis","volume":"3","author":"Chen","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"2026031913415789000_keaf677-B10","doi-asserted-by":"crossref","first-page":"101925","DOI":"10.1016\/j.berh.2023.101925","article-title":"Kidney involvement in systemic lupus erythematosus: From the patient assessment to a tailored treatment","volume":"37","author":"Mejia-Vilet","year":"2023","journal-title":"Best Prac Res Clin Rheumatol"},{"key":"2026031913415789000_keaf677-B11","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1191\/0961203306lu2271oa","article-title":"Sustained remission of lupus nephritis","volume":"15","author":"Barber","year":"2006","journal-title":"Lupus"},{"key":"2026031913415789000_keaf677-B12","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.ekir.2024.01.016","article-title":"Effect of sustained clinical remission on the risk of lupus flares and impaired kidney function in patients with lupus nephritis","volume":"9","author":"Gatto","year":"2024","journal-title":"Kidney Int Rep"},{"key":"2026031913415789000_keaf677-B13","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1177\/0961203317726376","article-title":"Sustained complete renal remission is a predictor of reduced mortality, chronic kidney disease and end-stage renal disease in lupus nephritis","volume":"27","author":"Pakchotanon","year":"2018","journal-title":"Lupus"},{"key":"2026031913415789000_keaf677-B14","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1093\/rheumatology\/kev003","article-title":"Assessment of long-term remission in lupus nephritis patients: a retrospective analysis over 30 years","volume":"54","author":"Fernandes das Neves","year":"2015","journal-title":"Rheumatology (United Kingdom)"},{"key":"2026031913415789000_keaf677-B15","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1136\/annrheumdis-2012-201940","article-title":"Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR\/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis","volume":"71","author":"Bertsias","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"2026031913415789000_keaf677-B16","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.kint.2021.05.021","article-title":"KDIGO 2021 clinical practice guideline for the management of glomerular diseases","volume":"100","author":"Rovin","year":"2021","journal-title":"Kidney Int"},{"key":"2026031913415789000_keaf677-B17","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.kint.2023.09.002","article-title":"KDIGO 2024 Clinical Practice Guideline for the management of lupus nephritis","volume":"105","author":"Rovin","year":"2024","journal-title":"Kidney Int"},{"key":"2026031913415789000_keaf677-B18","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/j.1523-1755.2004.00443.x","article-title":"The classification of glomerulonephritis in systemic lupus erythematosus revisited","volume":"65","author":"Weening","year":"2004","journal-title":"Kidney Int"},{"key":"2026031913415789000_keaf677-B19","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1002\/art.40930","article-title":"2019 European league against rheumatism\/American college of rheumatology classification criteria for systemic lupus erythematosus","volume":"71","author":"Aringer","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"2026031913415789000_keaf677-B20","first-page":"288","article-title":"Systemic lupus erythematosus disease activity index 2000","volume":"29","author":"Gladman","year":"2002","journal-title":"J Rheumatol"},{"key":"2026031913415789000_keaf677-B21","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1002\/art.1780400506","article-title":"The reliability of the Systemic Lupus International Collaborating Clinics\/American College of Rheumatology Damage Index in patients with systemic lupus erythematosus","volume":"40","author":"Gladman","year":"1997","journal-title":"Arthritis Rheum"},{"key":"2026031913415789000_keaf677-B22","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1093\/rheumatology\/keae381","article-title":"Immunosuppressives discontinuation after renal response in lupus nephritis: predictors of flares, time to withdrawal and long-term outcomes","volume":"64","author":"Panagiotopoulos","year":"2025","journal-title":"Rheumatology (Oxford, England)"},{"key":"2026031913415789000_keaf677-B23","doi-asserted-by":"crossref","first-page":"e584\u201393","DOI":"10.1016\/S2665-9913(23)00209-6","article-title":"Impact of low disease activity, remission, and complete remission on flares following tapering of corticosteroids and immunosuppressive therapy in patients with systemic lupus erythematous: a multinational cohort study","volume":"5","author":"Cho","year":"2023","journal-title":"Lancet Rheumatol"},{"key":"2026031913415789000_keaf677-B24","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1093\/rheumatology\/keab373","article-title":"Immunosuppressive therapy withdrawal after remission achievement in patients with lupus nephritis","volume":"61","author":"Zen","year":"2022","journal-title":"Rheumatology (United Kingdom)"},{"key":"2026031913415789000_keaf677-B25","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1136\/ard-2023-224762","article-title":"EULAR recommendations for the management of systemic lupus erythematosus: 2023 update","volume":"83","author":"Fanouriakis","year":"2024","journal-title":"Ann Rheum Dis"},{"key":"2026031913415789000_keaf677-B26","doi-asserted-by":"crossref","first-page":"e005877","DOI":"10.1136\/rmdopen-2025-005877","article-title":"Predictors of a successful glucocorticoid tapering and withdrawal in an inception cohort of patients with lupus nephritis and associations with long-term outcomes and damage accrual","volume":"11","author":"Michelakis","year":"2025","journal-title":"RMD Open"},{"key":"2026031913415789000_keaf677-B27","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.kint.2016.05.017","article-title":"A pathophysiology-based approach to the diagnosis and treatment of lupus nephritis","volume":"90","author":"Anders","year":"2016","journal-title":"Kidney Int"},{"key":"2026031913415789000_keaf677-B28","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1093\/ndt\/gfac304","article-title":"The influence of repeated flares in response to therapy and prognosis in lupus nephritis","volume":"38","author":"Perez-Arias","year":"2023","journal-title":"Nephrol Dialysis Transplant"},{"key":"2026031913415789000_keaf677-B29","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41572-025-00653-y","article-title":"Lupus nephritis","volume":"11","author":"Parodis","year":"2025","journal-title":"Nat Rev Dis Primers"},{"key":"2026031913415789000_keaf677-B30","doi-asserted-by":"crossref","first-page":"279","DOI":"10.2215\/CJN.05040513","article-title":"Renal flare as a predictor of incident and progressive CKD in patients with lupus nephritis","volume":"9","author":"Parikh","year":"2014","journal-title":"Clin J Am Soc Nephrol"},{"key":"2026031913415789000_keaf677-B31","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/s41584-023-00925-5","article-title":"Treatment of lupus nephritis: consensus, evidence and perspectives","volume":"19","author":"Mok","year":"2023","journal-title":"Nat Rev Rheumatol"},{"key":"2026031913415789000_keaf677-B32","doi-asserted-by":"crossref","first-page":"e000598","DOI":"10.1136\/lupus-2021-000598","article-title":"Renal response at 2 years post biopsy to predict long-term renal survival in lupus nephritis: a retrospective analysis of the Hopkins Lupus Cohort","volume":"9","author":"Cooper Blenkinsopp","year":"2022","journal-title":"Lupus Sci Med"},{"key":"2026031913415789000_keaf677-B33","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1136\/annrheumdis-2017-212732","article-title":"Changing patterns in clinical-histological presentation and renal outcome over the last five decades in a cohort of 499 patients with lupus nephritis","volume":"77","author":"Moroni","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"2026031913415789000_keaf677-B34","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.3899\/jrheum.170226","article-title":"Longterm data on disease flares in patients with proliferative lupus nephritis in recent years","volume":"44","author":"Yap","year":"2017","journal-title":"J Rheumatol"},{"key":"2026031913415789000_keaf677-B35","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1177\/0961203319829827","article-title":"Complete renal response at 12 months after induction therapy is associated with renal relapse-free rate in lupus nephritis: a single-center, retrospective cohort study","volume":"28","author":"Ichinose","year":"2019","journal-title":"Lupus"},{"key":"2026031913415789000_keaf677-B36","doi-asserted-by":"crossref","first-page":"e003158","DOI":"10.1136\/rmdopen-2023-003158","article-title":"Disease modification achievement in patients with lupus nephritis in a real-life setting: mission impossible?","volume":"9","author":"Panagiotopoulos","year":"2023","journal-title":"RMD Open"},{"key":"2026031913415789000_keaf677-B37","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.ard.2025.02.004","article-title":"Three years is the minimal effective duration of sustained clinical remission which prevents impaired kidney function and damage accrual in lupus nephritis","volume":"84","author":"Gatto","year":"2025","journal-title":"Ann Rheum Dis [Internet]"},{"key":"2026031913415789000_keaf677-B38","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1056\/NEJMoa2001180","article-title":"Two-year, randomized, controlled trial of belimumab in lupus nephritis","volume":"383","author":"Furie","year":"2020","journal-title":"New England J Med"},{"key":"2026031913415789000_keaf677-B39","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1016\/S0140-6736(21)00578-X","article-title":"Efficacy and safety of voclosporin versus placebo for lupus nephritis (AURORA 1): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial","volume":"397","author":"Rovin","year":"2021","journal-title":"Lancet"},{"key":"2026031913415789000_keaf677-B40","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1056\/NEJMoa2410965","article-title":"Efficacy and safety of obinutuzumab in active lupus nephritis","volume":"392","author":"Furie","year":"2025","journal-title":"New England J Med"},{"key":"2026031913415789000_keaf677-B41","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1093\/ndt\/gfv296","article-title":"Histologic versus clinical remission in proliferative lupus nephritis","volume":"32","author":"Malvar","year":"2017","journal-title":"Nephrol Dialysis Transplant"},{"key":"2026031913415789000_keaf677-B42","doi-asserted-by":"crossref","first-page":"sfae350","DOI":"10.1093\/ckj\/sfae350","article-title":"Predictive value of residual active histologic lesions on renal flare in lupus nephritis patients with clinical remission","volume":"17","author":"Hou","year":"2024","journal-title":"Clin Kidney J"},{"key":"2026031913415789000_keaf677-B43","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1177\/0961203321995251","article-title":"Correlation between the clinical remission and histological remission in repeat biopsy findings of quiescent proliferative lupus nephritis","volume":"30","author":"Das","year":"2021","journal-title":"Lupus"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keaf677\/65878428\/keaf677.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/65\/3\/keaf677\/65878428\/keaf677.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/65\/3\/keaf677\/65878428\/keaf677.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T17:42:06Z","timestamp":1773942126000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/doi\/10.1093\/rheumatology\/keaf677\/8379712"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,13]]},"references-count":43,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3,5]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keaf677","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,3]]},"published":{"date-parts":[[2025,12,13]]},"article-number":"keaf677"}}